A J Farmer

Summary

Affiliation: University of Oxford
Country: UK

Publications

  1. ncbi Incidence and costs of severe hypoglycaemia requiring attendance by the emergency medical services in South Central England
    A J Farmer
    National Institute for Health Research School for Primary Care Health Sciences, Department of Primary Health Care, University of Oxford, Oxford, UK
    Diabet Med 29:1447-50. 2012
  2. ncbi An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes
    Andrew Farmer
    Department of Primary Health Care Sciences, University of Oxford, Oxford, UK
    BMC Fam Pract 13:30. 2012
  3. ncbi Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes
    Andrew J Farmer
    Department of Primary Health Care, University of Oxford, and NIHR School for Primary Care Research, Oxford OX1 2ET, UK
    BMJ 344:e486. 2012
  4. ncbi Differences in insulin treatment satisfaction following randomized addition of biphasic, prandial or basal insulin to oral therapy in type 2 diabetes
    A J Farmer
    Diabetes Trials Unit, University of Oxford, Oxford, UK
    Diabetes Obes Metab 13:1136-41. 2011
  5. ncbi Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial
    A J Farmer
    Department of Primary Health Care, NIHR School of Primary Care Research, University of Oxford, UK
    Health Technol Assess 13:iii-iv, ix-xi, 1-50. 2009
  6. ncbi Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes
    J Hartweg
    Division of Public Health and Primary Health Care, University of Oxford, Old Road Campus, Headington, Oxford, UK
    Diabetologia 50:1593-602. 2007
  7. ncbi Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses
    D S Lasserson
    University of Oxford, Headington, UK
    Diabetologia 52:1990-2000. 2009
  8. ncbi Estimated 10-year cardiovascular risk in a British population: results of a national screening project
    H A W Neil
    Division of Public Health and Primary Health Care, University of Oxford, Oxford, UK
    Int J Clin Pract 62:1322-31. 2008
  9. ncbi Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials
    R J Stevens
    Department of Primary Care Health Sciences, University of Oxford, Woodstock Road, Oxford OX2 6GG, UK
    Diabetologia 55:2593-603. 2012
  10. ncbi Establishing an evidence base for frequency of monitoring glycated haemoglobin levels in patients with Type 2 diabetes: projections of effectiveness from a regression model
    J L Oke
    Department of Primary Health Care, University of Oxford and School of Primary Care Research, National Institute for Healthcare Research Somerville College, University of Oxford, UK
    Diabet Med 29:266-71. 2012

Detail Information

Publications15

  1. ncbi Incidence and costs of severe hypoglycaemia requiring attendance by the emergency medical services in South Central England
    A J Farmer
    National Institute for Health Research School for Primary Care Health Sciences, Department of Primary Health Care, University of Oxford, Oxford, UK
    Diabet Med 29:1447-50. 2012
    ..The aim was to estimate the incidence of severe hypoglycaemia requiring emergency ambulance assistance, its management and associated costs...
  2. ncbi An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes
    Andrew Farmer
    Department of Primary Health Care Sciences, University of Oxford, Oxford, UK
    BMC Fam Pract 13:30. 2012
    ..We evaluated the efficacy of a consultation-based intervention to support objectively-assessed adherence to oral glucose lowering medication (OGLM) compared to usual care among people with type 2 diabetes...
  3. ncbi Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes
    Andrew J Farmer
    Department of Primary Health Care, University of Oxford, and NIHR School for Primary Care Research, Oxford OX1 2ET, UK
    BMJ 344:e486. 2012
    ..To assess the effectiveness of self monitoring blood glucose levels in people with non-insulin treated type 2 diabetes compared with clinical management without self monitoring, and to explore the effects in specific patient groups...
  4. ncbi Differences in insulin treatment satisfaction following randomized addition of biphasic, prandial or basal insulin to oral therapy in type 2 diabetes
    A J Farmer
    Diabetes Trials Unit, University of Oxford, Oxford, UK
    Diabetes Obes Metab 13:1136-41. 2011
    ..We further investigated insulin treatment satisfaction between groups...
  5. ncbi Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial
    A J Farmer
    Department of Primary Health Care, NIHR School of Primary Care Research, University of Oxford, UK
    Health Technol Assess 13:iii-iv, ix-xi, 1-50. 2009
    ....
  6. ncbi Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes
    J Hartweg
    Division of Public Health and Primary Health Care, University of Oxford, Old Road Campus, Headington, Oxford, UK
    Diabetologia 50:1593-602. 2007
    ..To determine the effects of marine-derived n-3 polyunsaturated fatty acids (PUFA) on established and emerging lipid and lipoprotein cardiovascular risk markers in patients with type 2 diabetes...
  7. ncbi Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses
    D S Lasserson
    University of Oxford, Headington, UK
    Diabetologia 52:1990-2000. 2009
    ..We compared the effect of biphasic, basal or prandial insulin regimens on glucose control, clinical outcomes and adverse events in people with type 2 diabetes...
  8. ncbi Estimated 10-year cardiovascular risk in a British population: results of a national screening project
    H A W Neil
    Division of Public Health and Primary Health Care, University of Oxford, Oxford, UK
    Int J Clin Pract 62:1322-31. 2008
    ..To estimate 10-year cardiovascular disease (CVD) risk using the risk equation and risk categories of the Joint British Societies' Guidelines on Prevention of Cardiovascular Disease in Clinical Practice (2005)...
  9. ncbi Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials
    R J Stevens
    Department of Primary Care Health Sciences, University of Oxford, Woodstock Road, Oxford OX2 6GG, UK
    Diabetologia 55:2593-603. 2012
    ..Observational studies suggest that metformin may reduce cancer risk by approximately one-third. We examined cancer outcomes and all-cause mortality in published randomised controlled trials (RCTs)...
  10. ncbi Establishing an evidence base for frequency of monitoring glycated haemoglobin levels in patients with Type 2 diabetes: projections of effectiveness from a regression model
    J L Oke
    Department of Primary Health Care, University of Oxford and School of Primary Care Research, National Institute for Healthcare Research Somerville College, University of Oxford, UK
    Diabet Med 29:266-71. 2012
    ..Changes between two consecutive HbA1c tests result not only from deterioration or improvement in glycaemic control, but also from biovariability and measurement error. We model how this short-term variability impacts on HbA1c monitoring...
  11. ncbi Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes
    J Hartweg
    Division of Public Health and Primary Health Care, University of Oxford, Oxford, UK
    Diabetologia 50:250-8. 2007
    ....
  12. ncbi Knowledge of risk of developing diabetes mellitus among siblings of Type 2 diabetic patients
    A J Farmer
    Department of Public Health, University of Oxford, UK
    Diabet Med 16:233-7. 1999
    ..We set out to investigate the extent to which siblings of diabetic subjects perceived themselves likely to develop Type 2 diabetes mellitus (DM) when offered screening tests...
  13. ncbi Individual patient data meta-analysis of trials of self-monitoring of blood glucose in non-insulin treated type 2 diabetes: protocol for a systematic review
    A J Farmer
    Department of Primary Health Care, NIHR School of Primary Care Research, University of Oxford, Oxford, UK
    Prim Care Diabetes 3:117-21. 2009
    ..We will systematically examine these factors within the trials of SMBG to enable further investigation of the data through an individual patient data analysis (IPD)...
  14. ncbi Evidence for a dose effect of renin-angiotensin system inhibition on progression of microalbuminuria in Type 2 diabetes: a meta-analysis
    C L Blacklock
    National Institute for Health Research, School for Primary Care Research, Department of Primary Health Care, University of Oxford, Oxford, UK
    Diabet Med 28:1182-7. 2011
    ..We aimed to determine the extent of renin-angiotensin inhibitor dose-dependent effects from randomized trials carried out in a clinical setting...
  15. ncbi A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)
    P M Clarke
    Health Economics Research Centre, Department of Public Health, University of Oxford, Headington, Oxford, UK
    Diabetologia 47:1747-59. 2004
    ....